Protocol Ledger

NCT05072314 · Phase III · RECRUITING

Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial

Interventional Phase III clinical trial protocol NCT05072314 sponsored by Monash University in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-07-27 Enrollment: 4,300 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05072314
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)4,300 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05072314
Protocol FieldVerified Registry Value
NCT IdentifierNCT05072314
Consolidated Lead SponsorMonash University
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment4,300 participants (ESTIMATED)
Registered Start Date2022-07-27
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT05072314
Hospital Research SiteLocationSite Profile
Princess Alexandra HospitalWoolloongabba, AustraliaOpen Hospital Dossier ->
Flinders Medical CentreBedford Park, AustraliaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI